Tilray Brands Inc (TLRY) FinancialsTLRYTilray Brands Inc

Tilray Brands Inc (TLRY) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Beverage Alcohol Business, accounting for 39.5% of total sales, equivalent to $101.50M. Other significant revenue streams include Distribution Business and Cannabis Business. Understanding this composition is critical for investors evaluating how TLRY navigates market cycles within the Pharmaceuticals industry.

Evaluating the bottom line, Tilray Brands Inc maintains a gross margin of 27.61%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -6.27%, while the net margin is -15.57%. These profitability ratios, combined with a Return on Equity (ROE) of -10.38%, provide a clear picture of how effectively TLRY converts its operational activities into shareholder value.

In the context of the broader market, TLRY competes directly with industry leaders such as CGC and ACB. With a market capitalization of $464.05M, it holds a leading position in the sector. When comparing efficiency, TLRY's gross margin of 27.61% stands against CGC's 27.40% and ACB's -5.95%. Such benchmarking helps identify whether Tilray Brands Inc is trading at a premium or discount relative to its financial performance.

Tilray has reported a net loss of $49.572 million for Q4 2026, and its gross margin is only 29.93%, which is concerning for profitability.